EC359 |
カタログ番号GC39174 |
EC359 は 10.2 nM の Kd を持つ、強力で選択的、高親和性で経口的に活性な白血病抑制因子受容体 (LIFR) 阻害剤であり、LIFR と直接相互作用して LIF/LIFR 相互作用を効果的にブロックします。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2012591-09-0
Sample solution is provided at 25 µL, 10mM.
EC359 is a potent, selective, high affinity and orally active leukemia inhibitory factor receptor (LIFR) inhibitor with a Kd of 10.2 nM, which directly interacts with LIFR to effectively block LIF/LIFR interactions[1].
[1]. Viswanadhapalli S, et al. EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer. Mol Cancer Ther. 2019 Aug;18(8):1341-1354.
Average Rating: 5
(Based on Reviews and 27 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *